CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6. A total of 12 filers reported holding CLOVIS ONCOLOGY INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,915,000 | +5.3% | 1,950,000 | 0.0% | 0.26% | -3.4% |
| Q1 2021 | $1,818,000 | +1.3% | 1,950,000 | 0.0% | 0.26% | -6.4% |
| Q4 2020 | $1,795,000 | 0.0% | 1,950,000 | -0.3% | 0.28% | -14.5% |
| Q3 2020 | $1,795,000 | +2.1% | 1,955,000 | 0.0% | 0.33% | -4.6% |
| Q2 2020 | $1,758,000 | +0.7% | 1,955,000 | -0.3% | 0.35% | -20.1% |
| Q1 2020 | $1,745,000 | +2.3% | 1,960,000 | 0.0% | 0.43% | +30.8% |
| Q4 2019 | $1,705,000 | – | 1,960,000 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 49,064,000 | $44,037,000 | 1.28% |
| United Asset Strategies, Inc. | 1,955,000 | $1,758,000 | 0.35% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,992,000 | $1,773,000 | 0.15% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,664,000 | $2,398,000 | 0.08% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 2,170,000 | $1,953,000,000 | 0.04% |
| MACKAY SHIELDS LLC | 110,000 | $101,000 | 0.00% |
| UBS Group AG | 3,000 | $3,000 | 0.00% |
| NOMURA HOLDINGS INC | 68,267 | $5,000 | 0.00% |
| ROYAL BANK OF CANADA | 1,000 | $1,000 | 0.00% |
| FMR LLC | 1,728,000 | $1,556,000 | 0.00% |